Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
Top Cited Papers
- 1 November 2006
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 368 (9548) , 1660-1672
- https://doi.org/10.1016/s0140-6736(06)69571-8
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort studyThe Lancet, 2006
- Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control studyThe Lancet, 2005
- Cannabinoid physiology and pharmacology: 30 years of progressNeuropharmacology, 2004
- NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and OlderDiabetes, 2003
- Current Management Strategies for Coexisting Diabetes Mellitus and ObesityDrugs, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Leptin-regulated endocannabinoids are involved in maintaining food intakeNature, 2001
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in MenDiabetes Care, 1994
- Type II Diabetic Subjects Lose Less Weight Than Their Overweight Nondiabetic SpousesDiabetes Care, 1987